MXPA03001528A - Especificidad mejorada en el tratamiento de enfermedades. - Google Patents
Especificidad mejorada en el tratamiento de enfermedades.Info
- Publication number
- MXPA03001528A MXPA03001528A MXPA03001528A MXPA03001528A MXPA03001528A MX PA03001528 A MXPA03001528 A MX PA03001528A MX PA03001528 A MXPA03001528 A MX PA03001528A MX PA03001528 A MXPA03001528 A MX PA03001528A MX PA03001528 A MXPA03001528 A MX PA03001528A
- Authority
- MX
- Mexico
- Prior art keywords
- drug
- blocking group
- reduction
- diseases
- treatment
- Prior art date
Links
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 239000003814 drug Substances 0.000 abstract 6
- 229940079593 drug Drugs 0.000 abstract 6
- 230000000903 blocking effect Effects 0.000 abstract 4
- 238000006243 chemical reaction Methods 0.000 abstract 2
- 230000002503 metabolic effect Effects 0.000 abstract 2
- 230000009919 sequestration Effects 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000008878 coupling Effects 0.000 abstract 1
- 238000010168 coupling process Methods 0.000 abstract 1
- 238000005859 coupling reaction Methods 0.000 abstract 1
- 231100000433 cytotoxic Toxicity 0.000 abstract 1
- 230000001472 cytotoxic effect Effects 0.000 abstract 1
- 230000003013 cytotoxicity Effects 0.000 abstract 1
- 231100000135 cytotoxicity Toxicity 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 239000002207 metabolite Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/052—Imidazole radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/056—Triazole or tetrazole radicals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- Gastroenterology & Hepatology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22694800P | 2000-08-22 | 2000-08-22 | |
| US22687100P | 2000-08-22 | 2000-08-22 | |
| US22687000P | 2000-08-22 | 2000-08-22 | |
| PCT/US2000/033454 WO2002016382A1 (en) | 2000-08-22 | 2000-12-07 | Improved specificity in treatment of diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA03001528A true MXPA03001528A (es) | 2004-04-02 |
Family
ID=27397667
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA03001528A MXPA03001528A (es) | 2000-08-22 | 2000-12-07 | Especificidad mejorada en el tratamiento de enfermedades. |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP1351966A1 (cs) |
| JP (1) | JP2004518618A (cs) |
| KR (1) | KR20030040415A (cs) |
| CN (1) | CN1460109A (cs) |
| AU (1) | AU2001220806A1 (cs) |
| BR (1) | BR0017318A (cs) |
| CA (1) | CA2416748A1 (cs) |
| CZ (1) | CZ2003460A3 (cs) |
| HU (1) | HUP0302882A3 (cs) |
| IL (1) | IL154168A0 (cs) |
| MX (1) | MXPA03001528A (cs) |
| NO (1) | NO20030762L (cs) |
| PL (1) | PL365879A1 (cs) |
| TW (1) | TW200414903A (cs) |
| WO (1) | WO2002016382A1 (cs) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60331367D1 (de) | 2002-12-30 | 2010-04-01 | Angiotech Int Ag | Wirkstofffreisetzung von schnell gelierender polymerzusammensetzung |
| US20050182252A1 (en) | 2004-02-13 | 2005-08-18 | Reddy K. R. | Novel 2'-C-methyl nucleoside derivatives |
| CN100448879C (zh) * | 2004-07-22 | 2009-01-07 | 北京化工大学 | 一种无定型头孢呋辛酯的制备方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3984396A (en) * | 1971-06-01 | 1976-10-05 | Icn Pharmaceuticals, Inc. | 1-(β,-D-ribofuranosyl)-1,2,4-triazole acid esters |
| USRE29835E (en) * | 1971-06-01 | 1978-11-14 | Icn Pharmaceuticals | 1,2,4-Triazole nucleosides |
| US3798209A (en) * | 1971-06-01 | 1974-03-19 | Icn Pharmaceuticals | 1,2,4-triazole nucleosides |
| US3991078A (en) * | 1971-06-01 | 1976-11-09 | Icn Pharmaceuticals, Inc. | N-substituted 1,2,4-triazoles |
| US4093624A (en) * | 1977-01-31 | 1978-06-06 | Icn Pharmaceuticals, Inc. | 1,2,4-Thiadiazolidine-3,5-dione |
| JPS6426593A (en) * | 1987-07-21 | 1989-01-27 | Asahi Glass Co Ltd | Nucleoside derivative |
| US4925930A (en) * | 1988-11-02 | 1990-05-15 | Nucleic Acid Research Institute | Synthesis and anti-leukemic activity of alkyl-1-(β-D-ribofuranosyl)[1,2,4]triazole-3-carboximidates |
-
2000
- 2000-12-07 AU AU2001220806A patent/AU2001220806A1/en not_active Abandoned
- 2000-12-07 IL IL15416800A patent/IL154168A0/xx unknown
- 2000-12-07 EP EP00984134A patent/EP1351966A1/en not_active Withdrawn
- 2000-12-07 WO PCT/US2000/033454 patent/WO2002016382A1/en not_active Application Discontinuation
- 2000-12-07 PL PL00365879A patent/PL365879A1/xx not_active Application Discontinuation
- 2000-12-07 KR KR10-2003-7002538A patent/KR20030040415A/ko not_active Ceased
- 2000-12-07 JP JP2002521479A patent/JP2004518618A/ja active Pending
- 2000-12-07 CA CA002416748A patent/CA2416748A1/en not_active Abandoned
- 2000-12-07 MX MXPA03001528A patent/MXPA03001528A/es unknown
- 2000-12-07 HU HU0302882A patent/HUP0302882A3/hu unknown
- 2000-12-07 CZ CZ2003460A patent/CZ2003460A3/cs unknown
- 2000-12-07 BR BR0017318-5A patent/BR0017318A/pt not_active IP Right Cessation
- 2000-12-07 CN CN00819838A patent/CN1460109A/zh active Pending
-
2003
- 2003-02-07 TW TW092102500A patent/TW200414903A/zh unknown
- 2003-02-18 NO NO20030762A patent/NO20030762L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| BR0017318A (pt) | 2004-06-15 |
| AU2001220806A1 (en) | 2002-03-04 |
| HUP0302882A3 (en) | 2005-06-28 |
| PL365879A1 (en) | 2005-01-10 |
| TW200414903A (en) | 2004-08-16 |
| CA2416748A1 (en) | 2002-02-28 |
| NO20030762L (no) | 2003-04-22 |
| CN1460109A (zh) | 2003-12-03 |
| HUP0302882A2 (hu) | 2003-12-29 |
| CZ2003460A3 (cs) | 2003-10-15 |
| JP2004518618A (ja) | 2004-06-24 |
| KR20030040415A (ko) | 2003-05-22 |
| EP1351966A1 (en) | 2003-10-15 |
| WO2002016382A1 (en) | 2002-02-28 |
| NO20030762D0 (no) | 2003-02-18 |
| IL154168A0 (en) | 2003-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GEP20053688B (en) | Substituted-Triazolopyrimidines as Anticancer Agents | |
| WO2001039762A3 (en) | Use of taurolidine or taurultam for the manufacture of a medicament for the treatment of tumors of the central nervous system | |
| EG25822A (en) | Quinolinyl-pyrrolopyrazoles | |
| NZ514574A (en) | Novel method of treatment | |
| GEP20063799B (en) | Tropane derivatives useful in therapy | |
| NZ516347A (en) | Indanyl-substituted benzenecarboxamides, process for their preparation, their use as a medicament and pharmaceutical formulations containing them | |
| BG103641A (en) | Derivatives of arylsulphonylhydroxamic acid | |
| RS51688B (en) | METHOTREXATE CONCENTRATED SOLUTIONS | |
| DK1030670T3 (da) | Anvendelse af vitamin D-derivater til forstærkning af virkningen af cytotoksiske midler | |
| AP2001002288A0 (en) | Methods for treatment of sickle cell anemia. | |
| PT1309315E (pt) | Formulacao oral de desintegracao rapida de valdecoxib | |
| CY1107465T1 (el) | Μελαγατρανη για τη θepαπευτικη αντιμετωπιση φλεγμονων | |
| EP1622586A4 (en) | METHOD FOR PRODUCING TANNATE TABLETS, CAPSULES OR OTHER SOLID DOSAGE FORMS | |
| NZ591525A (en) | Methods of treatment of complicated skin and skin structure infections using single doses of oritavancin | |
| DE60031686D1 (de) | Pyrazinone, diese verbindungen enthaltende zusammenstellungen | |
| AP1901A (en) | Pharmaceutical composition for modified release insulin sensitiser. | |
| MXPA03001528A (es) | Especificidad mejorada en el tratamiento de enfermedades. | |
| MX2007006637A (es) | Uso de atazanavir para mejorar los parametros farmacocineticos de farmacos metabolizados por isoforma 1a1 de udp-glucuronosil- transferasa. | |
| GEP20043231B (en) | Resorcinol Composition | |
| AU4258601A (en) | Divided dose therapies with vascular damaging activity | |
| EP1347754A4 (en) | COMPOSITIONS FOR PREVENTION OF ADHESION | |
| WO2002040477A3 (en) | Saframycins, analogues and uses thereof | |
| RU99112967A (ru) | Способ лечения и профилактики дизентерии свиней | |
| WO2001007029A3 (en) | Substituted guanidines and the use thereof | |
| WO2001074381A3 (en) | Calpain inhibitors in cancer treatment |